Blod.in
India’s simplest and fastest blood donor portal.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Blod.in, operating as Blodin PVT LTD, is a health-tech entity based in Chennai, India, that has developed a platform to address inefficiencies in blood management for healthcare organizations. The company was established in 2021 by co-founders Varun Nair and Adithya Vikram. Blod.in provides a B2B software-as-a-service platform that digitizes and simplifies the daily operations of haematology departments within hospitals.
The company's core offering is Blod+, a software and logistics platform designed to streamline the sourcing and delivery of blood for hospitals and blood banks. This platform connects a network of over 150 hospitals with more than 40 blood banks, aiming to create a centralized blood management system. A key feature of the Blod+ platform is the reduction of the average sourcing time for blood from six hours to just over two hours. This efficiency helps to reduce the significant wastage of blood units that occurs annually in India. The platform facilitates the tracking of blood, streamlines documentation, and provides traceability for plasma fractionation, which is the process of separating components from blood plasma for therapeutic uses.
Blod.in's business model is centered on its technology platform, which serves hospitals, blood centers, and biopharmaceutical companies. Clients like CloudNine, Bewell, Sooriya Hospital, and IMAX Hospital have adopted the platform. The company has successfully completed over 4,800 blood order requests through its network. Financially, Blod.in has raised a total of $114K in funding over two seed rounds. The first round took place in December 2022, followed by a second round in August 2023 led by Ideas to Impacts. In April 2025, the company was acquired by Lytus Technologies Holdings.
Keywords: blood management, health-tech, haematology, logistics platform, plasma fractionation, blood bank network, medical software, healthcare supply chain, Chennai startup, Varun Nair, Adithya Vikram, Blod+, blood traceability, hospital inventory management, biopharmaceutical services, medical logistics, healthcare technology, blood services, transfusion medicine, digital health